Editorial (Hot Topic :Management of Perioperative Systemic Inflammation During Cardiopulmonary Bypass: We Need a Multimodal Approach)

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 3, 2012-12 ,pp. : 163-164

Bentham Science Publishers

Access to resources Recommend Favorite

Actual Knowledge of Systemic Inflammation Reaction During Cardiopulmonary Bypass

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 3, 2012-12 ,pp. : 165-169

Bentham Science Publishers

Access to resources Recommend Favorite

The Heparin Management Test - An improved method of assessing anticoagulation during cardiopulmonary bypass in the pediatric population

By Helft G.   Bartolomeo P.   Zaman A.G.   Worthley S.G.   Chokron S.   Le Pailleur C.   Beygui F.   Le Feuvre C.   Metzger J.-P.   Vacheron A.   Samama M.M.  

Thrombosis Research, Vol. 96, Iss. 6, 1999-12 ,pp. : 481-485

Elsevier

Access to resources Recommend Favorite

What is a normal lactate level during cardiopulmonary bypass?

By Svenmarker Staffan   Häggmark Sören   Östman Margareta  

Scandinavian Cardiovascular Journal, Vol. 40, Iss. 5, 2006-10 ,pp. : 305-311

Informa Healthcare

Access to resources Recommend Favorite

Review of the Fibrinolytic System: Comparison of Different Antifibrinolytics used During Cardiopulmonary Bypass

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 3, 2012-12 ,pp. : 175-179

Bentham Science Publishers

Access to resources Recommend Favorite